Browsing: Wegovy

By Patrick Wingrove (Reuters) – More than 200,000 prescriptions for copies of Novo Nordisk (NYSE:)’s weight-loss drug Wegovy are getting…

As a port strike stretching from New England to Texas halted nearly half of all trade coming into the U.S.,…

Health-care marketplace Sesame on Wednesday announced a new clinical weight loss program that will help eligible consumers access compounded versions…

By Patrick Wingrove NEW YORK (Reuters) – Older Americans are having little success getting prescriptions for weight-loss drug Wegovy covered…

London — Novo Nordisk trimmed its full-year profit outlook Wednesday after reporting weaker-than-expected quarterly sales of its popular weight loss drug Wegovy.…

By Ahmed Aboulenein WASHINGTON (Reuters) -Senator Bernie Sanders on Wednesday expressed confidence that Novo Nordisk (NYSE:) can be convinced to…

By Chad Terhune (Reuters) -Only one in four U.S. patients prescribed Novo Nordisk’s Wegovy or Ozempic for weight loss were…

By Andrew Silver SHANGHAI (Reuters) – Novo Nordisk (NYSE:)’s hugely popular weight-loss drug Wegovy has been approved in China, it…

By Jacob Gronholt-Pedersen and Bhanvi Satija COPENHAGEN (Reuters) – Novo Nordisk (NYSE:)’s popular obesity drug Wegovy helped women with a…

With weight-loss drugs like WeGovy and Ozempic dominating many of today’s consumer healthcare conversations, there’s a mounting concern for a…